Roughly 6 months after starting tezepelumab for severe asthma, many patients reduced OCS dependence and meaningfully improved ...

Patients with chronic rhinosinusitis with nasal polyps and uncontrolled asthma experienced greater improvements in lung ...

Filtration systems can improve indoor air quality and outcomes for patients with asthma, COPD and other respiratory diseases, ...

Asthma clinical remission among patients taking dupilumab is most likely to occur in those with increased baseline BEC and FeNO levels.

Nektar Therapeutics (Nasdaq: NKTR) announced today that new data from the ongoing REZOLVE-AD Phase 2b study of ...

The first head-to-head randomized clinical trial to compare biologics in severe chronic rhinosinusitis with nasal polyps (CRSwNP) and coexisting asthma showed an advantage to dupilumab (Dupixent) over ...

Coexisting asthma had to be physician-diagnosed for at least 12 months and inadequately controlled (Asthma Control Questionnaire ≥1.5) despite treatment with a low-, medium-, or high-dose inhaled ...

We all know that asthma impacts breathing. What may be less known is that the disease, which restricts our airways due to inflammatory responses, can be caused throughout our lifetime by a variety of ...

October is the ideal month to get protected, experts say, because flu cases typically begin climbing in November.